$4.00
0.194.99%
At close: Dec 15, 4:00 PM EST
$3.90
-0.10-2.50%
After Hours: 4:44 PM EST
Comments
Loading...
SAB Biotherapeutics Earnings Estimates, EPS & Revenue | NASDAQ:SABS | Benzinga
SAB Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$-0.210
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of SAB Biotherapeutics using advanced sorting and filters.
SAB Biotherapeutics (SABS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-13 | $-0.21 | $-0.51 | 58.8 % |
| Q2 | 2025-08-07 | $-1.09 | $-0.82 | -32.9 % |
| Q1 | 2025-05-09 | $-0.56 | $-0.72 | 22.2 % |
| Q4 | 2025-03-28 | $-1.23 | $-1.21 | -1.65 % |
SAB Biotherapeutics (SABS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-13 | $0 | $250.00K | -100.0 % |
| Q2 | 2025-08-07 | $0 | $260.00K | -100.0 % |
| Q1 | 2025-05-09 | $0 | $260.00K | -100.0 % |
| Q4 | 2025-03-28 | $114.70K | $120.00K | -4.42 % |
FAQ
When is SAB Biotherapeutics (NASDAQ:SABS) reporting earnings?
SAB Biotherapeutics (SABS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2025 for Q3.
What were the latest earnings per share (EPS) for SAB Biotherapeutics (NASDAQ:SABS)?
SAB Biotherapeutics (SABS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2025 for Q3 and the Actual EPS was $-0.21, which beat the estimate of $-0.51.
What were SAB Biotherapeutics’s (NASDAQ:SABS) revenues?
SAB Biotherapeutics (SABS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2025 for Q3 and the Actual Revenue was $0K, which missed the estimate of $250K.
Browse earnings estimates, EPS, and revenue on all stocks.
